Wedbush analyst Laura Chico raised the firm’s price target on Denali Therapeutics (DNLI) to $31 from $30 and keeps an Outperform rating on the ...
The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...
A proposed development with retail and 335 apartments nestled against Community Park in Springboro has been met with objections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback